Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Diab Rep. 2007 Jun;7(3):175-80.

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Author information

1
Division of Gastro-Hepatology, University of Turin, S. Giovanni Battista Hospital, Corso Bramante 88, Turin 10126, Italy. ebugianesi@yahoo.it

Abstract

The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.

PMID:
17547834
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center